Tinka Bakker,Joanna E Klopotowska,Dave A Dongelmans,Saeid Eslami,Wytze J Vermeijden,Stefaan Hendriks,Julia ten Cate,Attila Karakus,Ilse M Purmer,Sjoerd H W van Bree,Peter E Spronk,Martijn Hoeksema,Evert de Jonge,Nicolette F de Keizer,Ameen Abu-Hanna,Dorieke E.M. van Balen,Peter F. Schutte,Marnix J. Sigtermans,Emile M. Kuck,Erik J.M. van Kan,Marijke S. van der Steen,Liesbeth E. Bosma,Ralph O. Nowitzky,Albertus Beishuizen,Kris L.L. Movig,Elsbeth M. Wesselink,Rick J.W. Lammers,Cedric Lau,Joost B. Masselink,Rob J. Bosman,Dylan W. de Lange,Rob J. van Marum,Heleen van der Sijs,Eric J.F. Franssen,Hans Kieft,Walter M. van den Bergh,Wouter Bult,Maurits H. Renes,Peter W. de Feiter,Evert-Jan Wils,Nicole G.M. Hunfeld,Froukje Mulder,Michiel Duyvendak

Abstract:Summary Background Drug–drug interactions (DDIs) can harm patients admitted to the intensive care unit (ICU). Yet, clinical decision support systems (CDSSs) aimed at helping physicians prevent DDIs are plagued by low-yield alerts, causing alert fatigue and compromising patient safety. The aim of this multicentre study was to evaluate the effect of tailoring potential DDI alerts to the ICU setting on the frequency of administered high-risk drug combinations. Methods We implemented a cluster randomised stepped-wedge trial in nine ICUs in the Netherlands. Five ICUs already used potential DDI alerts. Patients aged 18 years or older admitted to the ICU with at least two drugs administered were included. Our intervention was an adapted CDSS, only providing alerts for potential DDIs considered as high risk. The intervention was delivered at the ICU level and targeted physicians. We hypothesised that showing only relevant alerts would improve CDSS effectiveness and lead to a decreased number of administered high-risk drug combinations. The order in which the intervention was implemented in the ICUs was randomised by an independent researcher. The primary outcome was the number of administered high-risk drug combinations per 1000 drug administrations per patient and was assessed in all included patients. This trial was registered in the Netherlands Trial Register (identifier NL6762) on Nov 26, 2018, and is now closed. Findings In total, 10 423 patients admitted to the ICU between Sept 1, 2018, and Sept 1, 2019, were assessed and 9887 patients were included. The mean number of administered high-risk drug combinations per 1000 drug administrations per patient was 26·2 (SD 53·4) in the intervention group (n=5534), compared with 35·6 (65·0) in the control group (n=4353). Tailoring potential DDI alerts to the ICU led to a 12% decrease (95% CI 5–18%; p=0·0008) in the number of administered high-risk drug combinations per 1000 drug administrations per patient, after adjusting for clustering and prognostic factors. Interpretation This cluster randomised stepped-wedge trial showed that tailoring potential DDI alerts to the ICU setting significantly reduced the number of administered high-risk drug combinations. Our list of high-risk drug combinations can be used in other ICUs, and our strategy of tailoring alerts based on clinical relevance could be applied to other clinical settings. Funding ZonMw.

Drug-drug interaction checking assisted by clinical decision support: a return on investment analysis

Overall performance of a drug–drug interaction clinical decision support system: quantitative evaluation and end-user survey

A critical evaluation of clinical decision support for the detection of drug–drug interactions

The effect of computerised decision support alerts tailored to intensive care on the administration of high-risk drug combinations, and their monitoring: a cluster randomised stepped-wedge trial

Optimising computerised decision support to transform medication safety and reduce prescriber burden: study protocol for a mixed-methods evaluation of drug–drug interaction alerts

Recommendations to improve the usability of drug-drug interaction clinical decision support alerts

Override rate of drug-drug interaction alerts in clinical decision support systems: A brief systematic review and meta-analysis

Identification of serious drug-drug interactions: Results of the partnership to prevent drug-drug interactions

Thinking Three-Dimensionally: A Self- and Externally-Controlled Approach to Screening for Drug-Drug-Drug Interactions Among High-Risk Populations

Impact of the use of a drug-drug interaction checker on pharmacist interventions involving well-known strong interactors

The Impact of Customized Screening Intervals on the Burden of Drug-Drug Interaction Alerts: An Interrupted Time Series Analysis

Drug use survey to identify significant drug-drug interactions and assess clinical importance in the outpatient setting of a tertiary care hospital

Development and validation of a clinical decision support system to prevent anticoagulant duplications

Does DDI-Predictor Help Pharmacists to Detect Drug-Drug Interactions and Resolve Medication Issues More Effectively?

Discovering clinical drug-drug interactions with known pharmacokinetics mechanisms using spontaneous reporting systems and electronic health records

Prescribers' reported acceptance and use of drug-drug interaction alerts: An Australian survey

Drug-drug interaction software in clinical practice: a systematic review

Consensus Recommendations for Systematic Evaluation of Drug–Drug Interaction Evidence for Clinical Decision Support

Informatics confronts drug–drug interactions

Ability of machine-learning based clinical decision support system to reduce alert fatigue, wrong-drug errors, and alert users about look alike, sound alike medication

DDInter: an online drug–drug interaction database towards improving clinical decision-making and patient safety